Skip to main content

New Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?

fda

The result is that patients are being prescribed pricey new medications that have not been tested as rigorously, said lead researcher Jonathan Darrow, an assistant professor at Harvard Medical School.



from WebMD Health https://ift.tt/38bFG66
via IFTTT

Comments

Popular posts from this blog

The Future of Autoimmune Disorders: Psoriatic Disease

What's being done to help people with psoriatic disease? We get a look at the ever-changing picture from a rheumatologist. from WebMD Health https://ift.tt/5P6ZHyd via IFTTT

Long COVID Experts: ‘So Incredibly Clear What’s at Stake’

It’s estimated that more than a third of people who have had COVID-19 experience neurological complications such as brain fog that persist or develop 3 months after infection. And two thirds of so-called long haulers still have neurological symptoms after 6 months. from WebMD Health https://ift.tt/mx1j6QD via IFTTT

Study: Black Men Twice as Likely to Develop Prostate Cancer as Whites

A review of men seen at VA hospitals found that Black veterans had nearly twice the incidence of localized and advanced prostate cancer as white men. from WebMD Health https://ift.tt/3Knscs2 via IFTTT